Cardiovascular Safety of Obesity Drugs
- Cardio
- 08/03/2016
According to a study published in JAMA , the cardiovascular safety of obesity drug combination naltrexone-bupropion is uncertain especially in light of the unanticipated early termination of a...
READ MORE